Keynote Address

Presenter:
Dr. Nora Volkow
Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health
Share this video:
Scroll to Top

The British Columbia Centre for Excellence in HIV/AIDS Laboratory has discontinued gp-41 resistance testing as T-20 (enfuvirtide/Fuzeon) is no longer available in Canada as of March 31, 2025